BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to H1658 cell line is 7
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABCC1 | 51 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1658 | Erlotinib | RT-PCR followed by CFA and SFA | NA | 0.2 | 0.0212 | 31069016 |
| ABCG2 | 74 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1658 | Erlotinib | RT-PCR followed by CFA and SFA | NA | 0.2 | 0.1739 | 31069016 |
| BMI1 | 1066 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1658 | Erlotinib | RT-PCR followed by CFA and SFA | NA | 0.2 | 0.1135 | 31069016 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1658 | Erlotinib | RT-PCR followed by CFA and SFA | NA | 0.2 | 0.5461 | 31069016 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1658 | Erlotinib | RT-PCR followed by CFA and SFA | NA | 0.2 | 0.6448 | 31069016 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1658 | Erlotinib | RT-PCR followed by CFA and SFA | NA | 0.2 | 0.7582 | 31069016 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1658 | Erlotinib | RT-PCR followed by CFA and SFA | NA | 0.2 | 0.5695 | 31069016 |